Novo Nordisk PE Ratio 2006-2018 | NVO

Current and historical p/e ratio for Novo Nordisk (NVO) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Novo Nordisk PE ratio as of January 22, 2019 is 19.07.
Novo Nordisk PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-01-22 48.19 19.12
2018-09-30 47.14 $2.52 18.71
2018-06-30 46.12 $2.56 18.02
2018-03-31 49.25 $2.47 19.94
2017-12-31 52.79 $2.32 22.76
2017-09-30 47.36 $2.29 20.68
2017-06-30 41.75 $2.25 18.56
2017-03-31 33.37 $2.26 14.77
2016-12-31 34.22 $2.23 15.34
2016-09-30 39.68 $2.20 18.04
2016-06-30 50.82 $2.11 24.09
2016-03-31 51.21 $1.99 25.73
2015-12-31 53.94 $2.01 26.83
2015-09-30 50.37 $1.92 26.23
2015-06-30 50.85 $1.85 27.49
2015-03-31 49.58 $1.85 26.80
2014-12-31 38.71 $1.73 22.38
2014-09-30 43.56 $1.77 24.61
2014-06-30 42.26 $1.79 23.61
2014-03-31 41.76 $1.76 23.75
2013-12-31 33.18 $1.69 19.58
2013-09-30 30.39 $1.66 18.33
2013-06-30 27.83 $1.58 17.63
2013-03-31 29.00 $1.45 20.00
2012-12-31 28.74 $1.36 21.13
2012-09-30 27.79 $1.27 21.85
2012-06-30 25.59 $1.19 21.54
2012-03-31 24.43 $1.15 21.28
2011-12-31 19.94 $1.11 17.97
2011-09-30 17.22 $1.07 16.15
2011-06-30 21.68 $1.02 21.25
2011-03-31 21.67 $0.95 22.76
2010-12-31 19.20 $0.89 21.47
2010-09-30 16.79 $0.80 21.04
2010-06-30 13.82 $0.75 18.42
2010-03-31 13.15 $0.72 18.32
2009-12-31 10.70 $0.67 15.87
2009-09-30 10.55 $0.65 16.17
2009-06-30 9.12 $0.64 14.17
2009-03-31 8.04 $0.57 14.10
2008-12-31 8.42 $0.55 15.20
2008-09-30 8.39 $0.48 17.48
2008-06-30 10.81 $0.43 24.97
2008-03-31 11.34 $0.33 34.69
2007-12-31 10.49 $0.28 37.34
2007-09-30 9.79 $0.31 31.18
2007-06-30 8.78 $0.28 31.36
2007-03-31 7.32 $0.37 19.79
2006-12-31 6.67 $0.34 19.84
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $117.412B $16.962B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $350.628B 16.44
Pfizer (PFE) United States $253.175B 14.27
Novartis AG (NVS) Switzerland $205.567B 17.62
Merck (MRK) United States $204.560B 17.73
AbbVie (ABBV) United States $134.627B 11.95
Eli Lilly (LLY) United States $123.506B 21.71
Sanofi (SNY) France $104.035B 12.88
GlaxoSmithKline (GSK) United Kingdom $96.892B 13.02
AstraZeneca (AZN) United Kingdom $92.577B 11.49
Bristol-Myers Squibb (BMY) United States $81.806B 13.47